`FILED: NEW YORK COUNTY CLERK 07/14/2022 03:20 PM
`NYSCEF DOC. NO. 92
`NYSCEF DOC. NO. 92
`
`INDEX NO. 654817/2021
`INDEX NO. 654817/2021
`RECEIVED NYSCEF: 07/14/2022
`RECEIVED NYSCEF: 07/14/2022
`
`EXHIBIT 51
`
`
`
`FILED: NEW YORK COUNTY CLERK 07/14/2022 03:20 PM
`NYSCEF DOC. NO. 92
`Message
`
`INDEX NO. 654817/2021
`
`RECEIVED NYSCEF: 07/14/2022
`
`GROUP
`
`ADMINISTRATIVE
`[/O=COWEN/OU=EXCHANGE
`Pae, Alexander
`(FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=ALEXANDER.PAE7EE]
`5/20/2019
`10:29:14
`PM
`William J Plovanic
`[khuang@obalon.com];
`[wplovanic@obalon.com]
`Kelly Huang
`Projectomega
`[/O=COWEN/OU=EXCHANGE
`ADMINISTRATIVE
`GROUP
`(FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=PROJECTOMEGABDF]
`RE: Re: Obalon-Baronova
`Obalon NDA_Baronova.pdf;
`image001.png;
`
`Obalon NDA_Jon Wecker.pdf
`
`From:
`
`Sent:
`To:
`CC:
`
`Subject:
`Attachments:
`
`Kelly
`
`and Bill,
`
`NDAs
`See attached
`-
`-Bill
`let us know
`
`signed
`if you
`
`and Jon Wecker.
`by the Baronova
`reached
`out
`to Jon for a potential
`
`Please
`meeting.
`
`send
`
`us back
`
`executed
`
`versions.
`
`Best Regards,
`Alex Pae
`
`COWEN
`Pae
`Alexander
`T646
`562 1173 M631
`www.cowen.com
`
`339 1404
`
`.......................................................................................................................................................................................................................................................................................................................................................................................
`From:
`Pae, Alexander
`10:55 AM
`20, 2019
`Sent: Monday,
`May
`To: Kelly Huang
`<khuang@obalon.com>;
`<Projectomega@cowen.com>
`Cc: Projectomega
`Subject:
`FW: Re: Obalon-Baronova
`
`William
`
`J Plovanic
`
`<wplovanic@obalon.com>
`
`Kelly
`
`and Bill,
`
`reached
`Ann
`Last Thursday,
`who was
`overview
`below)
`Obalon
`management.
`
`out
`brought
`
`from Lumira.
`Brunk
`to Gerry
`Gerry
`board
`in by the
`to lead Baranova.
`
`teaser
`the
`sent
`Jon reached
`
`at Baronova
`to Jon Wecker
`out
`to Ann
`for availability
`
`(company
`to meet
`with
`
`Although
`
`Jon will
`in Boston,
`based
`at Obalon; Wednesday
`meeting
`Let us know
`your
`availabilities
`
`through
`be in San Diego
`Thursday
`to 3pm or Thursday
`morning
`back. We've
`sent
`Jon the NDA.
`
`morning
`to refer
`
`this week
`through
`
`and is available
`11 am.
`
`for a management
`
`Overview
`BAROnova
`based
`is a Silicon
`BAROnova
`Valley
`TransPyloric
`BAROnova's
`obesity.
`- a proven
`mechanism
`rapid
`satiety
`procedure
`outpatient
`15-minute
`weight-loss.
`in sustained
`to assist
`trial
`designed
`to evaluate
`the
`
`venture-backed
`Shuttle®*
`
`for
`has developed
`that
`company
`and more
`to slow gastric
`is designed
`emptying
`(TPS®)
`a simple
`loss.
`The TPS is placed
`significant
`weight
`for driving
`during
`endoscopically
`for up to 12 months
`in patients
`in a similar
`manner.
`The device
`resides
`and is removed
`- a twelve-month
`multicenter
`US pivotal
`completed
`its ENDObesity
`II Study
`Recently
`and effectiveness
`of
`the TransPyloric
`Shuttle.
`safety
`
`a novel
`
`non-surgical
`which
`creates
`
`solution
`longer
`
`Best Regards,
`Alex Pae
`
`COWEN
`Pae
`Alexander
`T646
`562 1173 M631
`www.cowen.com
`
`339 1404
`
`
`
`FILED: NEW YORK COUNTY CLERK 07/14/2022 03:20 PM
`NYSCEF DOC. NO. 92
`
`INDEX NO. 654817/2021
`
`RECEIVED NYSCEF: 07/14/2022
`
`<ion@baronova.com>
`Jon Wecker
`From:
`10:20 AM
`20, 2019
`Sent: Monday,
`May
`<Alexander.Pae@cowen.com>
`To: Pae, Alexander
`Cc: Miller,
`Ann <Ann.Miller@cowen.com>;
`Subject:
`Re: Re: Obalon
`
`Tuminelli,
`
`Vance
`
`<Vance.Tuminelli@cowen.com>
`
`[External
`
`Thanks
`
`through
`
`Jon
`
`Email]
`Alex. We will
`about
`3 pm,
`
`get
`
`and
`
`this
`
`back
`
`to you
`
`today.
`
`also
`
`thursday
`
`morning
`
`I am available
`through
`about
`
`to meet
`
`in Carlsbad
`
`this Wednesday
`
`morning
`
`11am.
`
`Jonathan
`
`Wecker
`
`| BAROnova,
`
`Inc.
`
`3
`
`617.721.0406
`
`E jon@baronova.com|http://www.baronova.com
`
`Linked
`
`in
`
`Confidentiality
`contain
`may
`of
`purpose
`is prohibited.
`and
`
`destroy
`
`Notice:
`
`This
`
`email,
`
`confidential,
`conducting
`If you
`copies
`
`all
`
`this
`original
`
`any
`including
`or privileged
`
`proprietary
`with
`business
`BAROnova,
`received
`and
`are not
`of
`Thank
`the
`message.
`
`is for
`the
`attachments,
`It should
`information.
`unauthorized
`Inc. Any
`the
`intended
`for
`you
`
`use
`sole
`be used
`
`of
`intended
`the
`or disseminated
`
`and
`
`recipient(s)
`for
`the
`or distribution
`
`by
`
`use,
`inform
`
`disclosure,
`sender
`the
`
`review,
`please
`recipient,
`your
`cooperation.
`
`<Alexander.Pae@cowen.com>
`9:33 AM
`20, 2019
`
`Pae, Alexander
`From:
`Sent: Monday,
`May
`To: Jon Wecker
`Cc: Miller,
`Subject:
`
`Tuminelli,
`Ann;
`RE: Re: Obalon
`
`Vance
`
`review.
`this week
`
`if you would
`
`like to meet management.
`
`[External
`
`Email]
`
`Jon,
`
`your
`
`NDA for
`your
`
`availability
`
`See attached
`Let us know
`
`Best Regards,
`Alex Pae
`
`COWEN
`Pae
`Alexander
`T 646 562 1173 M 631 339 1404
`www.cowen.com
`
`
`
`FILED: NEW YORK COUNTY CLERK 07/14/2022 03:20 PM
`NYSCEF DOC. NO. 92
`
`INDEX NO. 654817/2021
`
`RECEIVED NYSCEF: 07/14/2022
`
`Dear Ann,
`
`Gerry
`
`Brunk
`
`from Lumira
`
`forwarded
`
`me the Obalon
`
`summary.
`
`I've been
`
`in the industry
`
`for
`
`the last dozen
`
`years
`
`and was
`
`brought
`
`in recently
`
`by the board
`
`to lead Baronova.
`
`Specifically,
`
`I'm pursuing
`
`some
`
`new angles
`
`for
`
`their
`
`recently
`
`approved
`
`TPS device
`
`and am interested
`
`in seeing
`
`how Obalon
`
`and Baronova
`
`might
`
`fit
`
`together.
`
`I'm based
`
`in Boston
`
`but
`
`in San Diego
`
`through
`
`Thursday
`
`this week
`
`for DDW and several meetings.
`
`It would
`
`be a very
`
`convenient
`
`time
`
`to visit with
`
`them.
`
`Looking
`
`forward
`
`to hearing
`
`back
`
`from you.
`
`Best,
`
`Jon
`
`Jonathan
`
`Weeker
`
`| BAROnova,
`
`Inc.
`
`( 617.721.0406
`* jon@baronova.com|http://www.baronova.com
`
`Image
`
`Get Outlook
`
`for
`
`iOS
`
`are confidential.
`unauthorized
`
`This message
`
`accurate,
`contained
`
`and any attachments
`this
`email.
`and destroy
`Any
`immediately
`system
`is subject
`to review
`and
`retention.
`Nothing
`with
`respect
`to the
`purchase
`or sale of any
`security
`illegal.
`Neither
`Cowen
`Inc. nor any of
`its affiliates
`complete
`or up to date,
`nor
`shall Cowen
`herein.
`
`sender
`the
`please
`intended
`the
`are not
`If you
`recipient,
`notify
`to or
`from our
`sent
`All email
`use or dissemination
`is prohibited.
`or solicitation
`contained
`shall
`be considered
`an offer
`in this
`would
`be
`in any jurisdiction
`where
`such
`an offer
`or solicitation
`represent
`that
`any of
`the
`contained
`herein
`information
`("Cowen")
`have
`to update
`any opinions
`or other
`information
`any
`
`responsibility
`
`is
`
`
`
`FILED: NEW YORK COUNTY CLERK 07/14/2022 03:20 PM
`NYSCEF DOC. NO. 92
`
`INDEX NO. 654817/2021
`
`RECEIVED NYSCEF: 07/14/2022
`1-way. Individual NDA
`Revised 07-14-2016
`Page I of 2
`
`OBALON
`
`THERAPEUTICS,
`
`INC.
`
`NON-DISCLOSURE
`
`AGREEMENT
`
`Agreement
`This Non-Disclosure
`/24 H C an
`between
`corporation
`("Obalon").
`
`(this
`
`|tr 0G .
`
`2011,
`Delaware
`
`"Agreement")
`
`is made
`
`the
`
`as of
`("Recipient"),
`
`7
`
`day of
`and Obalon
`
`Therapeutics,
`
`Inc.,
`
`a
`
`and Recipient
`Obalon
`desire
`Purpose").
`In connection
`"Business
`to disclose
`to Recipient
`for Obalon
`Purpose
`and to protect
`such confidential
`
`discussions
`to begin
`regarding
`with
`Obalon
`such
`discussions,
`certain
`confidential
`information
`information
`from unauthorized
`
`a business
`opportunity
`recognize
`and Recipient
`of Obalon
`to be used
`use and disclosure.
`
`(the
`of mutual
`interest
`that
`there
`is a need
`the Business
`for
`
`only
`
`In consideration
`
`of
`
`the disclosure
`
`of such information
`
`by Obalon,
`
`Recipient
`
`hereby
`
`agrees with Obalon
`
`as
`
`follows:
`
`1.
`disclosed
`of
`time
`
`this Agreement,
`of
`For puÆoses
`by Obalon
`to Recipient
`that:
`such
`if disclosed
`disclosure;
`(ii)
`the circumstances,
`or
`under
`(iii)
`or proprietary.
`
`disclosure;
`be confidential
`
`"Confulential
`if disclosed
`in writing,
`(i)
`is identified
`as
`orally,
`a person
`
`exercising
`
`Information"
`
`means
`is marked
`"confidential"
`
`technical
`any
`"confidential"
`"proprietary"
`
`reasonable
`
`judgment
`
`or
`business
`
`information
`or business
`"proprietary"
`the
`at
`or
`such
`to
`
`of
`the time
`at
`would
`understand
`
`2.
`
`Confidential
`
`Information
`
`will
`
`not
`
`include
`
`any information
`
`that:
`
`(i)
`
`is now or
`thereafter
`becomes
`on the part of Recipient;
`
`generally
`
`known
`
`or available
`
`to the public,
`
`through
`
`no act or omission
`
`such information
`
`from Obalon
`
`restriction
`
`as
`
`(ii)
`
`(iii)
`
`(iv)
`
`by Recipient
`was known
`to use or disclosure;
`
`prior
`
`to receiving
`
`and without
`
`is rightfully
`provides
`
`acquired
`it without
`
`party who
`from a third
`by Recipient
`or
`restriction
`as to use or disclosure;
`
`has the right
`
`to disclose
`
`it and who
`
`is independently
`
`developed
`
`by Recipient
`
`without
`
`access
`
`to any Confidential
`
`Information.
`
`3.
`
`Recipient
`
`agrees:
`
`(i)
`
`(ii)
`
`(iii)
`
`to maintain
`
`all Confidential
`
`Information
`
`in strict
`
`confidence;
`
`not
`
`to disclose
`
`Confidential
`
`Information
`
`to any third
`
`parties;
`
`and
`
`to
`not
`provisions
`the extent
`give Obalon
`or
`prevent
`
`Information
`use Confidential
`3 will
`not
`this Section
`of
`law or
`required
`by any
`advance
`reasonable
`such disclosure.
`limit
`
`for
`restrict
`
`for
`purpose
`except
`any
`from disclosing
`Recipient
`provided
`that Recipient
`regulation;
`notice
`of such
`required
`disclosure
`
`Purpose.
`Business
`the
`Information
`Confidential
`uses its reasonable
`efforts
`in order
`to enable
`Obalon
`
`The
`to
`to
`to
`
`4.
`
`containing
`
`Upon Obalon's
`or consisting
`
`Recipient
`request,
`of Confidential
`
`to Obalon
`return
`will
`promptly
`thereof
`Information
`and all copies
`
`all
`
`tangible
`
`(including
`
`or embodiments
`items
`copies).
`electronic
`
`acknowledges
`Recipient
`All Confidential
`of Obalon.
`5.
`the sole and exclusive
`remains
`Information
`property
`or
`by license
`and agrees
`that nothing
`rights
`to Recipient,
`be construed
`as granting
`will
`in this Agreement
`any
`or proprietary
`in or
`or other
`intellectual
`to any Confidential
`copyright
`or any patent,
`Information
`otherwise,
`property
`rights
`of Obalon,
`as specified
`except
`in this Agreement.
`
`CONFIDENTIAL
`
`INFORMATION
`
`IS PROVIDED
`
`"AS IS".
`
`7.
`
`Recipientacknowledges
`
`that
`
`the unauthorized
`
`use or disclosure
`
`of any Confidential
`
`Information
`
`would
`
`Recipient initial:
`
`(blueorblackink)
`
`
`
`FILED: NEW YORK COUNTY CLERK 07/14/2022 03:20 PM
`NYSCEF DOC. NO. 92
`
`INDEX NO. 654817/2021
`
`RECEIVED NYSCEF: 07/14/2022
`1-way, Individual NDA
`Revised 07-14-2016
`Page 1 of 2
`
`cause Obalon
`to incur
`irreparable
`acknowledges
`Recipient
`Accordingly,
`use or disclosure
`any unauthorized
`law or otherwise.
`have
`at
`may
`
`harm and significant
`will
`that Obalon
`its Confidential
`
`of
`
`of which may
`the degree
`damages,
`the right
`to obtain
`have
`immediate
`in addition
`to any other
`Information,
`
`be difficult
`equitable
`rights
`
`or
`
`to ascertain.
`to enjoin
`relief
`that
`remedies
`
`it
`
`This
`
`Agreement
`
`will
`8.
`California
`its body
`(excluding
`the subject
`statement
`regarding
`or written,
`oral
`communications,
`this Agreement,
`not
`assign
`may
`assignment
`without
`such
`consent
`
`be construed,
`interpreted,
`law controlling
`conflicts
`of
`matter
`of
`this Agreement
`between
`the parties
`regarding
`in whole
`or
`in part, without
`will
`be void.
`
`in accordance
`and applied
`This
`of
`law).
`Agreement
`and supersedes
`all prior
`the subject
`matter
`Obalon's
`prior
`written
`
`of
`
`of
`the State
`the laws
`with
`is the complete
`and exclusive
`understandings
`agreements,
`of
`this Agreement.
`Recipient
`and any attempted
`consent,
`
`and
`
`to 18 U.S.C
`Pursuant
`9.
`trade
`secret
`law for
`or State
`or
`local
`government
`State,
`or
`investigating
`reporting
`filed
`in a lawsuit
`or other
`
`§ 1833(b)(1),
`the disclosure
`either
`official,
`directly
`a suspected
`violation
`if such
`proceeding,
`
`filing
`
`of
`
`or civilly
`makes
`(i)
`and (ii)
`solely
`in a complaint
`
`under
`any Federal
`liable
`to a Federal,
`in confidence
`the purpose
`of
`for
`document
`or other
`
`Recipient
`be held
`cannot
`criminally
`secret
`of a trade
`that
`(A) Recipient
`to an attorney
`or
`or
`indirectly,
`or
`(B) Recipient
`makes
`law;
`is made
`under
`seal.
`
`10.
`will
`This
`Agreement
`from the date of
`last disclosure
`
`on the date first
`commence
`of Confidential
`Information
`
`set
`
`forth
`above
`by Obalon,
`
`and will
`at which
`
`for
`in effect
`remain
`terminate.
`it will
`time
`
`five
`
`(5)
`
`years
`
`IN WITNESS
`officers
`or
`
`WHEREOF,
`representatives.
`
`authorized
`
`the parties
`
`hereto
`
`have executed
`
`this Non-Disclosure
`
`Agreement
`
`by their
`
`duly
`
`OBALON
`
`THERAPEUTICS,
`
`INC.:
`
`RECIPIENT:
`
`Signature:
`
`Printed
`
`Name:
`
`Title:
`
`(psignin blue or black ink, NO e-signatures)
`
`Signature:
`
`Printed
`
`(sigg in blue or black ink, NO e-signa
`Ó/
`US fl
`
`V)
`
`Name:
`
`)
`
`7
`
`Title:
`
`61
`
`,
`
`
`
`FILED: NEW YORK COUNTY CLERK 07/14/2022 03:20 PM
`NYSCEF DOC. NO. 92
`
`INDEX NO. 654817/2021
`
`RECEIVED NYSCEF: 07/14/2022
`
`OBALON
`
`THERAPEUTICS,INC.
`
`NON-DISCLOSURE
`
`AGREEMENT
`
`1-way,1ndividual NDA
`Resed 07.14-20%
`Page 1of 2.
`
`A reement
`L C-
`
`Tis '
`
`reeme
`
`")
`M\
`
`is made
`(
`
`"
`
`W-
`
`as of
`
`the
`Recipient"),
`
`lay of
`and Obalon
`
`The
`
`AV
`W ic
`
`.
`Ïnc., a
`
`20
`Delaware
`
`This
`, between
`corporation
`
`Non-Disclosure
`
`tW E
`
`("Obalon").
`
`"Business
`for Obalon
`Purpose
`
`Obalon
`and Recipient
`desire
`Purpose").
`In connection
`to disclose
`to Recipient
`to protect
`such
`confidential
`
`and
`
`to begin
`discussions
`with
`such
`discussions,
`certain
`confidential
`information
`
`regarding
`Obalon
`information
`from unauthorized
`
`a business
`opportunity
`and Recipient
`recognize
`of Obalon
`to be used
`use and disclosure.
`
`of mutual
`(the
`interest
`that
`there
`is a need
`for
`the Business
`
`only
`
`In consideration
`
`of
`
`the disclosure
`
`of
`
`such
`
`inform.ation
`
`by Obalon,
`
`Recipient
`
`hereby
`
`agrees with Obalon
`
`as
`
`follows:
`
`1.
`disclosed
`time
`of
`
`For
`purposes
`of
`this
`Agreement,
`by Obalon
`to Recipient
`that:
`such
`if disclosed
`disclosure;
`(ii)
`under
`the circumstances,
`(iii)
`or proprietary.
`
`or
`
`disclosure;
`be confidential
`
`(i)
`
`Information"
`
`"Confidential
`means
`if disclosed
`in writing.
`is marked
`as "confidential"
`is identified
`orally,
`a person
`reasonable
`
`exercising
`
`technical
`any
`"confidential"
`"proprietary"
`
`or
`business
`
`judgment
`
`infannm
`
`or business
`or
`
`"proprietary
`the tim
`at
`would
`undc
`
`.
`
`2.
`
`Confidential
`
`Information
`
`will
`
`not
`
`include
`
`any
`
`information
`
`that:
`
`(i)
`
`(ii)
`
`is now
`on the
`
`or
`part
`
`thereafter
`becomes
`of Recipient;
`
`generally
`
`known
`
`or available
`
`to the public,
`
`through
`
`no act or omission
`
`prior
`
`to receiving
`
`such
`
`information
`
`from Obalon
`
`and without
`
`restriction
`
`as
`
`known
`was
`by Recipient
`to use or disclosure;
`
`(iii)
`
`(iv)
`
`is rightfully
`provides
`
`acquired
`it without
`
`from a third
`by Recipient
`party
`as to use or disclosure;
`restriction
`
`who
`or
`
`has the right
`
`to disclose
`
`it and who
`
`is independently
`
`developed
`
`by Recipient
`
`without
`
`access
`
`to any Confidential
`
`Information.
`
`3.
`
`Recipient
`
`agrees:
`
`(i)
`
`(ii)
`
`(iii)
`
`to maintain
`
`all Confidential
`
`Information
`
`in strict
`
`confidence;
`
`not
`
`to disclose
`
`Confidential
`
`Information
`
`to any
`
`third
`
`parties;
`
`and
`
`use
`
`to
`not
`provisions
`extent
`the
`Obalon
`give
`or
`prevent
`
`Confidential
`Section
`
`this
`of
`required
`by
`reasonable
`such
`
`limit
`
`for
`restrict
`
`Information
`not
`3 will
`regulation;
`law or
`any
`of
`notice
`advance
`disclosure.
`
`purpose
`any
`Recipient
`provided
`required
`such
`
`for
`except
`from disclosing
`that Recipient
`disclosure
`
`Purpose.
`Business
`the
`informanon
`Confidential
`efforts
`its reasonable
`uses
`Obaton
`to enable
`in order
`
`The
`to
`to
`m
`
`or emW imS
`items
`copw
`electronic
`
`property
`
`acknowl©
`Recipient
`of Obalon.
`by heense
`to Recipient,
`rights
`any
`or proprietary
`intellectual
`property
`or other
`
`or
`
`s
`
`4.
`
`containing
`
`Upon
`or
`
`Obalon's
`
`consisting
`
`Recipient
`request,
`of Confidential
`
`will
`promptly
`Information
`
`and
`
`to Obalon
`return
`thereof
`all copies
`
`all
`
`tangible
`
`(including
`
`Confidential
`
`All
`agrees
`
`5.
`that
`and
`in or
`otherwise,
`of Obalon,
`rights
`
`in this
`nothing
`to any Confidential
`as specified
`except
`
`exclusive
`
`as granting
`copyright
`
`and
`sole
`the
`remains
`Information
`be construed
`will
`Agreement
`or any patent,
`Information
`in this Agreement.
`IS PROVIDED
`
`6.
`
`7.
`
`ALL
`
`CONFIDENTIAL
`
`INFORMATION
`
`Recipient
`
`acknowledges
`
`that
`
`the
`
`unauthorized
`
`"AS
`
`IS",
`
`use or disclosure
`
`of any
`
`Confidential
`
`Information
`
`Recipient
`
`Inith
`
`
`
`FILED: NEW YORK COUNTY CLERK 07/14/2022 03:20 PM
`NYSCEF DOC. NO. 92
`
`INDEX NO. 654817/2021
`
`RECEIVED NYSCEF: 07/14/2022
`
`1~way,ladividual NDA
`Revised07- I4-2016
`Page1of 2
`
`of which may be difficult
`the degree
`damages,
`immediate
`equitable
`to obtain
`have the right
`or
`to any other
`rights
`in addition
`Information,
`
`to ascertain.
`to enjoin
`relief
`that
`remedies
`
`it
`
`of
`
`harm and significant
`irreparable
`to incur
`cause Obalon
`will
`acknowledges
`that Obalon
`Recipient
`Accordingly,
`its Confidential
`use or disclosure
`any unauthorized
`law or otherwise.
`at
`may have
`in accordance
`and applied
`be construed,
`will
`This Agreement
`8.
`interpreted,
`law). This Agreement
`conflicts
`law controlling
`of
`of
`its body
`California
`(excluding
`all prior
`the subject matter
`and supersedes
`of
`this Agreement
`statement
`regarding
`the subject matter
`between
`oral or written,
`the parties
`communications,
`regarding
`prior written
`in whole
`or
`in part, without
`may not assign
`Obalon's
`this Agreement,
`will
`such consent
`be void.
`assignment
`without
`
`the State of
`of
`the laws
`with
`and exclusive
`is the complete
`and
`understandings
`agreements,
`Recipient
`this Agreement
`of
`and any attempted
`consent,
`
`any Federal
`under
`liable
`or civilly
`be held criminally
`cannot
`Recipient
`to 18 U.S.C § 1833(b)(1),
`Pursuant
`9.
`to a FederaL
`in confidence
`makes
`(A) Recipient
`of a trade secret
`that
`secret
`or State trade
`law for
`the disclosure
`(i)
`of
`the purpose
`for
`and (ii)
`or
`or
`to an attorney
`local
`government
`either
`or
`indirectly,
`solely
`official,
`State,
`directly
`document
`or other
`in a complaint
`makes
`or
`a suspected
`(B) Recipient
`of
`violation
`law; or
`investigating
`reporting
`or other
`if such filing
`is made under
`seal.
`in a lawsuit
`filed
`proceeding,
`
`will
`This Agreement
`10.
`last disclosure
`from the date of
`
`on the date first
`commence
`of Confidential
`Information
`
`set
`
`and will
`at which
`
`for
`in effect
`remain
`terminate.
`time it will
`
`five
`
`(5) years
`
`above
`forth
`by Obalon,
`hereto have executed
`
`Agreement
`
`by their
`
`duly
`
`/
`
`Z
`
`IN WITNESS
`officers
`
`or
`
`WHEREOF,
`representatives.
`
`authorized
`
`the parties
`
`this Non-Disclosure
`
`OBALON
`
`THERAPEUTICS,
`
`INC.:
`
`Signature:
`
`(sign in blue or black ink. NO e-signatures)
`
`RECIPIENT:
`
`Signat
`
`e:
`
`Printed
`
`Name:
`
`Title:
`
`Printed
`
`N
`
`e:
`
`c(cid:11)0A
`
`.
`
`Title:
`
`C YÊ>(cid:26)
`
`(s m bl
`
`or black nk NO e-s en ures)
`
`